Affiliation:
1. Department of Orthopaedic Surgery, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-Cho, Chuo-ku, Hyogo, Kobe 650-0017, Japan
Abstract
Advanced glycation end-products (AGEs) play a critical supportive role during musculoskeletal disorders via glycosylation and oxidative stress. Though apocynin, identified as a potent and selective inhibitor of NADPH oxidase, has been reported to be involved in pathogen-induced reactive oxygen species (ROS), its role in age-related rotator cuff degeneration has not been well clarified. Therefore, this study aims to evaluate the in vitro effects of apocynin on human rotator cuff-derived cells. Twelve patients with rotator cuff tears (RCTs) participated in the study. Supraspinatus tendons from patients with RCTs were collected and cultured. After the preparation of RC-derived cells, they were divided into four groups (control group, control + apocynin group, AGEs group, AGEs + apocynin group), and gene marker expression, cell viability, and intracellular ROS production were evaluated. The gene expression of NOX, IL-6, and the receptor for AGEs (RAGE) was significantly decreased by apocynin. We also examined the effect of apocynin in vitro. The results showed that ROS induction and increasing apoptotic cells after treatment of AGEs were significantly decreased, and cell viability increased considerably. These results suggest that apocynin can effectively reduce AGE-induced oxidative stress by inhibiting NOX activation. Thus, apocynin is a potential prodrug in preventing degenerative changes of the rotor cuff.
Subject
Microbiology (medical),Molecular Biology,General Medicine,Microbiology
Reference43 articles.
1. Prevalence and risk factors of a rotator cuff tear in the general population;Yamamoto;J. Shoulder Elb. Surg.,2010
2. The effect of hypercholesterolemia on rotator cuff disease;Abboud;Clin. Orthop. Relat. Res.,2010
3. Repetition strain injury: A review of current understanding;McDermott;Med. J. Aust.,1986
4. Glycation, carbonyl stress and AGEs inhibitors: A patent review;Jahan;Expert Opin. Ther. Pat.,2015
5. Uremic Toxicity of Advanced Glycation End Products in CKD;Stinghen;J. Am. Soc. Nephrol.,2016
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献